Publication/Creation Date

February 22 2019

Creators/Contributors

Proteus Digital Health (creator)
Federal Communications Commission (FCC) (contributor)
Marlene H. Dortch (contributor)
Otsuka Pharmaceutical (contributor)

Description

Letter to Ms. Marlene H. Dortch, Secretary of the Federal Communications Commission, from Proteus Digital Health, written to introduce the Commission to Proteus’ work in “digital medicines,” and to highlight its implications for patient well-being and reducing healthcare costs. Proteus also has an interest in the Commission’s “Connected Care” Notice of Inquiry in WC Docket No. 18-213, and, for the reasons set forth below, urges the Commission to (1) ensure that projects featuring use of digital medicines are eligible for funding under the Connected Care pilot program, and (2) continue to promote broadband connectivity in unserved and underserved areas, an effort that is necessary if we are to see optimal use of telehealth applications.

Augments

Treating, Sensing

Technology Keywords

Ingestible Electronic Devices, Ingestible Capsules, Ingestible Sensors, Digital Pills, Digital Medicine, Tele-Medicine, Ingestible Event Marker (IEM) Sensor, Smartphone Applications, Patch

Keywords

Medical, Health, Regulation, Compliance, Communication, Ethics, Government

Marketing Keywords

Proteus Digital Health, Abilify MyCite, Otsuka Pharmaceutical

Source

https://ecfsapi.fcc.gov/file/10222267684157/FINAL%20PROTEUS%20LETTER%202.22.19.pdf